Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures

Cochrane Database of Systematic Reviews

Volumn 2021, Issue 12, 2002, Pages

  Handoll, Helen HG ^a   Farrar, Mark J ^b   McBirnie, Julie ^c   Tytherleigh Strong, Graham M ^d   Milne, Alan A ^e   Gillespie, William J ^f  

^a TEESSIDE UNIVERSITY   (United Kingdom)

^b POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

^e QUEEN MARGARET HOSPITAL   (United Kingdom)

^f UNIVERSITY OF HULL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

BANDAGE; CLINICAL TRIAL; HIP FRACTURE; HUMAN; LUNG EMBOLISM; META ANALYSIS; POSTOPERATIVE COMPLICATION; REVIEW; VEIN THROMBOSIS;

ANTICOAGULANTS; BANDAGES; FIBRINOLYTIC AGENTS; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HIP FRACTURES; HUMANS; POSTOPERATIVE COMPLICATIONS; PULMONARY EMBOLISM; VENOUS THROMBOSIS;

EID: 84921702520     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD000305     Document Type: Article

References (88)

1. Barsotti J, Dabo B, Andreu J, Alison D, Leroy Y, Delahousse B. Prevention of deep vein thrombosis (DVT) by Enoxaparine (LovenoxR) after surgery for fracture of femoral neck. One daily injection of 40 mg versus two daily injections of 20 mg. Thrombosis and Haemostasis 1987;58:241. x-wiley/crsRef/19518277 [MEDLINE: 1991093825]
2. Barsotti J, Gruel Y, Rosset P, Favard L, Dabo B, Andreu J, et al. Comparative double-blind study of two dosage regimens of low-molecular weight heparin in elderly patients with a fracture of the neck of the femur. Journal of Orthopaedic Trauma 1990;4:371-5. x-wiley/crsRef/19518278
3. Bergqvist D, Efsing HO, Hallbook T, Hedlund T. Thromboembolism after elective and post-traumatic hip surgery - a controlled prophylactic trial with dextran 70 and low-dose heparin. Acta Chirurgica Scandinavica 1979;145:213-8. x-wiley/crsRef/19518280 [MEDLINE: 1980038470]
4. Borris LC, Lassen MR, Poulsen KA, Jensen HP. Thromboembolic complications after hip fracture - prophylaxis with low molecular weight vs. unfractionated heparin [Abstract]. Thrombosis and Haemostasis 1995;73:1104. x-wiley/crsRef/19518282
5. Checketts RG, Bradley JG. Low-dose heparin in femoral neck fractures. Injury 1974;6(1):42-4. x-wiley/crsRef/19518284 [MEDLINE: 1975021847]
6. Dulic B, Radulovic N, Bumbasirevic M, Milosevic I. The thromboprophylactic effect of a low-molecular weight heparin (Embolex NM) in hip fracture surgery [Poster]. In: Final programme of the 20th World Congress SICOT 96; 1996 Aug 18 -23; Amsterdam. 1996:483. x-wiley/crsRef/19518286
7. Eskander MB, Limb D, Stone MH, Furlong AJ, Shardlow D, Stead D, et al. Sequential mechanical and pharmacological thromboprophylaxis in the surgery of hip fractures. International Orthopaedics 1997;21(4):259-61. x-wiley/crsRef/19518288
8. Araujo A, Atallah A. Individual patient data (as supplied 4 July 1998). Data tables. x-wiley/crsRef/19518290
9. Atallah A. personal communication May 26 1998. x-wiley/crsRef/19518291
10. Silvestre JMS. Estudo controlado randomizado do uso da heparina de baixo peso molecular e da compressao pneumatica externa intermitente na prevencao da trombose venbosa profunda em pacientes submetidos a tratamento circurgico de fraturas dos membros inferiores [dissertation] [Randomised controlled trial with low molecular weight heparin and intermittent pneumatic compression in the prevention of deep venous thrombosis in patients submitted to a surgical treatment of lower limb fractures] [dissertation]. Sao Paulo (SP): Escola Paulista de Medicina, 1994. x-wiley/crsRef/19518292
11. Fisher CG, Blachut PA, Salvian AJ, Meek RN, O'Brien PJ. Effectiveness of pneumatic leg compression devices for the prevention of thromboembolic disease in orthopaedic trauma patients: A prospective, randomized study of compression alone versus no prophylaxis. Journal of Orthopaedic Trauma 1995;9(1):1-7. x-wiley/crsRef/19518294 [MEDLINE: 1995230415]
12. Fisher CG, Blachut PA, Salvian AJ, Meek RN, O'Brien PJ. Effectiveness of pneumatic leg compression devices for the prevention of thromboembolic disease in orthopaedic trauma patients [Abstract]. Journal of Bone and Joint Surgery. British Volume 1991;73 Suppl 1:49-50. x-wiley/crsRef/19518295
13. Fisher CG, Blachut PA, Salvian AJ, Meek RN, O'Brien PJ. Effectiveness of pneumatic leg compression devices for the prevention of thrombo-embolic disease in orthopaedic trauma patients [Abstract]. Journal of Bone and Joint Surgery. British Volume 1992;74 Suppl 3:269. x-wiley/crsRef/19518296
14. Fisher CG, Blachut PA, Salvian AJ, Meek RN, O'Brien PJ. Effectiveness of pneumatic leg compression devices for the prevention of thromboembolic disease in orthopaedic trauma patients [Abstract]. Journal of Bone and Joint Surgery. British Volume 1992;74 Suppl 3:292. x-wiley/crsRef/19518297
15. Galasko CS, Edwards DH, Fearn CB, Barber HM. The value of low dosage heparin for the prophylaxis of thromboembolism in patients with transcervical and intertrochanteric femoral fractures. Acta Orthopaedica Scandinavica 1976;47:276-82. x-wiley/crsRef/19518299 [MEDLINE: 76249457]
16. Galasko CSB, Edwards DH, Fearn CBD'A. A controlled clinical trial to investigate the use of low dosage heparin for the prevention of thromboembolism in patients with fractured femoral necks [abstract]. Journal of Bone and Joint Surgery. British Volume 1973;55(1):213-4. x-wiley/crsRef/19518300
17. Gallus AS, Hirsh J, Tuttle RJ, Trebilcock R, O'Brien SE, Carroll JJ, Minden JH, Hudecki SM. Small subcutaneous doses of heparin in prevention of venous thrombosis. New England Journal of Medicine 1973;288:545-51. x-wiley/crsRef/19518302 [MEDLINE: 1973091273]
18. Gargan MF, Lawrence J, Thomas H, Trundle H, Fairbank JTC. Thromboembolic prophylaxis following hip fracture using a foot pump (A-V impulse system). Unpublished trial - abstract presented at 1st European Congress of Orthopaedics Paris 1993. x-wiley/crsRef/19518304
19. Hartman JT, Pugh JL, Smith RD, Robertson WW, Yost RP, Janssen HF. Cyclic seqential compression of the lower limb in prevention of deep venous thrombosis. Journal of Bone and Joint Surgery. American Volume 1982;64(7):1059-62. x-wiley/crsRef/19518306 [MEDLINE: 1983007391]
20. Hoffmann R, Kohler A, Platz A, Bino M, Trentz O. Wrksamkeit des niedermolekularen heparins Certoparin in der huftchirurgie. In: Spannagel U, Wolf H, editors(s). Niedermolekulare heparine in der pravention und behandlung postoperativer thromboembolien. Stuttgart: Georg Thieme, Verlag, 1996:12-7. x-wiley/crsRef/19518308 [3-13-104471-3]
21. Platz A, Hoffmann R, Kohler A, Bischof T, Trentz O. Prevention of thromboembolism in hip fracture: unfractionated heparin versus low molecular weight heparin (a prospective, randomized study) [Thromboembolieprophylaxe bei Huftfraktur: Unfraktioniertes Heparin versus niedermolekulares Heparin (eine prospektive, randomisierte Untersuchung)]. Zeitschrift fur Unfallchirurgie und Versicherungsmedizin 1993;86:184-8. x-wiley/crsRef/19518309 [MEDLINE: 1994176263]
22. Jorgensen PS, Knudsen JB, Broeng L, Josephsen IL, Bjerregaard P, Hagen KK, et al. The thromboprophylactic effect of low molecular weight heparin (Fragmin) in hip fracture surgery. A placebo controlled trial [Den tromboprofylaktiske effekt af lavmolekylaer heparin (Fragmin) ved hoftefrakturkirurgi. En placebokontrolleret undersogelse.]. Ugeskrit for Laeger 1993;155:706-8. x-wiley/crsRef/19518311 [MEDLINE: 1993206383]
23. Jorgensen PS, Knudsen JB, Broeng L, Josephsen L, Bjerregaard P, Hagen K, et al. The thromboprophylactic effect of a low-molecular-weight heparin (Fragmin) in hip fracture surgery. A placebo-controlled study. Clinical Orthopaedics and Related Research 1992;278:95-100. x-wiley/crsRef/19518312 [MEDLINE: 92224509]
24. Jorgensen PS, Torholm C, Knudsen JB, Boeng L, Josefson L, Bjerregaard P. Thromboprophylactic effect of a low molecular weight heparin (Fragmin) in acute hip fracture surgery. A placebo controlled study. Thrombosis and Haemostasis 1989;62:525. x-wiley/crsRef/19518313
25. Jorgensen PS, Strandberg C, Willejorgensen P, Torholm C, Neergaard K, Paaske BP, et al. Early preoperative thromboprophylaxis with Klexane(R) in hip fracture surgery: A placebo-controlled study. Clinical and Applied Thrombosis/Hemostasis 1998;4(2):140-2. x-wiley/crsRef/19518315
26. Jorgensen PS, Strandberg C, Wille-Jorgensen P, Torholm C, Neergard K, Paaske BP, at al. Early preoperative thromboprophylaxis with Klexane in hip fracture surgery. A placebo controlled study. Unpublished report - dated 1995. x-wiley/crsRef/19518316
27. Jorgensen PS, Torholm C, Paaske BP, Rasmussen SW, Christensen SW, Strandberg C, et al. Early preoperative thromboprophylaxis with Klexane (R) in hip fracture surgery - a placebo controlled study [Abstract]. Acta Orthopaedica Scandinavica Supplementum 1996;272:18-9. x-wiley/crsRef/19518317
28. Kew J, Lee YL, Davey IC, Ho SY, Fung KC, Metreweli C. Deep vein thrombosis in elderly Hong Kong Chinese with hip fractures detected with compression ultrasound and Doppler imaging: incidence and effect of low molecular weight heparin. Archives of Orthopaedic and Trauma Surgery 1999;119(3-4):156-8. x-wiley/crsRef/19518319
29. Kiviluoto O, Julkunen H, Honkonen K. Prevention of venous thromboemboli with low doses of heparin in patients with proximal femur fractures [Vorbeugung venoser Thromboembolism durch niedrig dosiertes Heparin bei Patienten mit proximalen Femurbruchen]. Zentralblatt fur Chirurgie 1980;105(7):460-4. x-wiley/crsRef/19518321 [MEDLINE: 1981017940]
30. Lahnborg G. Effect of low-dose heparin and dihydroergotamine on frequency of postoperative deep-vein thrombosis in patients undergoing post-traumatic hip surgery. Acta Chirurgica Scandinavica 1980;146:319-22. x-wiley/crsRef/19518323 [MEDLINE: 1981129559]
31. Lassen MR, Borris LC, Christiansen HM, Moller Larsen F, Knudsen VE, Boris P, et al. Prevention of thromboembolism in hip-fracture patients. Comparison of low-dose heparin and low-molecular-weight heparin combined with dihydroergotamine. Archives of Orthopaedic and Trauma Surgery 1989;108(1):10-3. x-wiley/crsRef/19518325 [MEDLINE: 1989117330]
32. Eriksson B, Risberg B. A prospective double-blind trial of a low molecular weight heparin once daily compared with a conventional low-dose heparin three times daily prevent pulmonary embolism and venous thrombosis in patients with hip fracture [letter; comment]. Journal of Trauma 1990;30:753-4. x-wiley/crsRef/19518327 [MEDLINE: 1990279012]
33. Monreal M, Lafoz E, Navarro A, Granero X, Caja V, Caceres E, et al. A prospective double-blind trial of a low molecular weight heparin once daily compared with conventional low-dose heparin three times daily to prevent pulmonary embolism and venous thrombosis in patients with hip fracture [see comments]. Journal of Trauma 1989;29:873-5. x-wiley/crsRef/19518328 [MEDLINE: 1989293943]
34. Monreal M. A prospective double-blind trial of a low molecular weight heparin once daily compared with conventional low-dose heparin three times daily to prevent pulmonary embolism and venous thrombosis in patients with hip fracture [letter; comment]. Journal of Trauma 1990;30:754. x-wiley/crsRef/19518329
35. Morris GK, Mitchell JRA. Preventing venous thromboembolism in elderly patients with hip fractures: studies of low-dose heparin, dipyridamole, aspirin, and flurbiprofen. BMJ 1977;1:535-7. x-wiley/crsRef/19518331 [MEDLINE: 1977135711]
36. Moskovitz PA, Ellenberg SS, Feffer HL, Kenmore PI, Neviaser RJ, Rubin BE, Varma VM. Low-dose heparin for prevention of venous thromboembolism in total hip arthroplasty and surgical repair of hip fractures. Journal of Bone and Joint Surgery. American Volume 1978;60:1065-70. x-wiley/crsRef/19518333 [MEDLINE: 1979067871]
37. Pini M, Tagliaferri A, Manotti C, Lasagni F, Rinaldi E, Dettori AG. Low molecular weight heparin (Alfa LHWH) compared with unfractionated heparin in prevention of deep-vein thrombosis after hip fractures. International Angiology 1989;8:134-9. x-wiley/crsRef/19518335 [MEDLINE: 1990079100]
38. Sourmelis S, Patoulis G, Tzortzis G. Prevention of deep vein thrombosis with low molecular weight heparin in fractures of the hip [Abstract]. Journal of Bone and Joint Surgery. British Volume 1995;77 Suppl 2:173. x-wiley/crsRef/19518337
39. Sourmelis S, Patoulis G, Tzortzis G. Prevention of deep vein thrombosis with low molecular weight heparin in fractures of the hip. Journal of Bone and Joint Surgery. British Volume 1995;77 Suppl 2:173. x-wiley/crsRef/19518339
40. Stranks GJ, MacKenzie NA, Grover ML, Fail T. The A-V Impulse System reduces deep-vein thrombosis and swelling after hemiarthroplasty for hip fracture. Journal of Bone and Joint Surgery. British Volume 1992;74:775-8. x-wiley/crsRef/19518341 [MEDLINE: 1992406980]
41. Svend-Hansen H, Bremerskov V, Gotrik J, Ostri P. Low-dose heparin in proximal femoral fractures: Failure to prevent deep-vein thrombosis. Acta Orthopaedica Scandinavica 1981;52:77-80. x-wiley/crsRef/19518343 [MEDLINE: 1981156282]
42. Taberner DA, Poller L, Thomson JM, Lemon G, Weighill FJ. Randomized study of adjusted versus fixed low dose heparin prophylaxis of deep vein thrombosis in hip surgery. British Journal of Surgery 1989;76:933-5. x-wiley/crsRef/19518345 [MEDLINE: 1990029349]
43. Roise O, Nurmohamed M, Reijnders P, Touzard R, Stiekema J, Bachman F, et al. A multicentre, randomised, assessor-blind, pilot study comparing the efficacy in the prophylaxis of DVT and the safety of Orgaran (Org 10172), Fragmin, Clexane/Lovenox in patients undergoing surgery for a fractured hip [abstract 273]. Thrombosis and Haemostasis 1993;69(6):620. x-wiley/crsRef/19518347
44. The TIFDED Study Group. Thromboprophylaxis in hip fracture surgery: A pilot study comparing danaparoid, enoxaparin and dalteparin. Haemostasis 1999;29(6):310-7. x-wiley/crsRef/19518348
45. Williams WE, Wisniewski TF. Pre-operative anticoagulant prophylaxis in elderly patients with proximal femur fractures [Abstract]. Journal of Bone and Joint Surgery. British Volume 1994;76 Suppl 2 & 3:79. x-wiley/crsRef/19518350
46. Lawrence JC, Xabregas A, Gray L, Ham JM. Seasonal variation in the incidence of deep vein thrombosis. British Journal of Surgery 1977;64:777-80. x-wiley/crsRef/19518352 [MEDLINE: 1978061565]
47. Xabregas A, Gray L, Ham JM. Heparin prophylaxis of deep vein thrombosis in patients with a fractured neck of the the femur. Medical Journal of Australia 1978;1:620-2. x-wiley/crsRef/19518353 [MEDLINE: 1978246445]
48. Anglen JO, Bagby C, George R. A randomized comparison of sequential gradient calf compression to intermittent plantar compression for prevention of venous thrombosis in orthopaedic trauma patients- preliminary reports [Abstract]. Orthopaedic Transactions 1997;21(2):562. x-wiley/crsRef/19518355
49. Anglen JO, Bagby C, George R. A randomized comparison of sequential-gradient calf compression with intermittent plantar compression for prevention of venous thrombosis in orthopedic trauma patients: preliminary results. American Journal of Orthopedics 1998;27(1):53-8. x-wiley/crsRef/19518356
50. Arrington ED, Allgood B, Stannard J, Martin S, Bucknell A. Deep vein thrombosis prophylaxis following hip fractures [Abstract]. Orthopaedic Transactions 1997;21(4):1394-5. x-wiley/crsRef/19518358
51. Eriksson BI, Bauer KA, Lassen MR, Turpie AG for the Steering Committee of the Pentasaccharide in Hip-Fracture Surgery Study. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip fracture surgery. New England Journal of Surgery 2001;345(18):1298-304. x-wiley/crsRef/19518360
52. Geerts W, Jay R, Code K, Szalai J, Chen E, Saibil E, Hamilton P. Thromboprophylaxis after major trauma - a double-blind RCT comparing low dose Heparin (LDH) and the low molecular weight heparin (LMWH), Enoxaparin [Abstract]. Journal of Trauma 1995;39(1):159. x-wiley/crsRef/19518362
53. Geerts WH, Jay RM, Code KI, Chen EL, Szalai JP, Saibil EA, Hamilton PA. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. New England Journal of Medicine 1996;335(10):701-7. x-wiley/crsRef/19518363
54. Knudsen JB, Torholm C, Jorgensen PK, Hagen K, Broeng L, Josefson L, et al. Effect on coagulation parameters of low molecular weight heparin (fragmin) in elective and acute hip surgery [Abstract]. Thrombosis and Haemostasis 1989;62:523. x-wiley/crsRef/19518365
55. Knudson MM, Lewis FR, Clinton A, Atkinson K, Megerman J. Prevention of venous thromboembolism in trauma patients. Journal of Trauma 1994;37(3):480-7. x-wiley/crsRef/19518367
56. Nordlund S, Holmqvist B, Johansson H. Prophylaxis of thrombosis in fractures of the femoral neck [Trombosprofylax vid collumfrakturer]. Opuscula Medica 1961;6(9):266-70. x-wiley/crsRef/19518369
57. Wilson D, Cooke EA, McNally MA, Mollan RA. Whole blood thromboelastographic profiles following hip fracture - a comparison of low molecular weight heparin, dextran 70 and mechanical prophylaxis [Abstract]. Journal of Bone and Joint Surgery. British Volume 1999;81 Suppl 3:296. x-wiley/crsRef/19518371
58. Haentjens P, Buffels R. Thromboembolic prophylaxis in trauma patients: A comparison between a fixed dose and an individually adjusted dose of a low molecular weight heparin (CY216). Journal of Bone and Joint Surgery. British Volume 1995;77 Suppl 2:173. x-wiley/crsRef/19518373
59. Haentjens P. Thromboembolic prophylaxis in orthopaedic trauma patients: A comparison between a fixed dose and an individually adjusted dose of a low molecular weight heparin (nadroparin calcium). Injury 1996;27(6):385-90. x-wiley/crsRef/19518374
60. Krska Z, Kudrna K, Kvasnicka J, Zeman M, Peskova M. Prostheses of the hip joint in orthopaedics and traumatology - thromboembolics complications [Nahrady kycelniho kloubu v ortopedii a tramatologii - tromboembolicke komplikace]. Prakticky Lehar 2001;81(4):192-6. x-wiley/crsRef/19518376
61. Monreal M, Lafoz E, Arias A, Casals A. Role of granulocytes in the development of venous thrombosis in patients with hip fractures. Haemostasis 1991;21(1):45-50. x-wiley/crsRef/19518378
62. Monreal M. A prospective double-blind trial of a low molecular weight heparin once daily compared with conventional low-dose heparin three times daily to prevent pulmonary embolism and venous thrombosis in patients with hip fracture [letter; comment]. Journal of Trauma 1990;30:754. x-wiley/crsRef/19518379
63. Perhoniemi V, Vuorinen J, Myllynen P, Kivioja A, Lindevall K. The effect of enoxaparin in prevention of deep venous thrombosis in hip and knee surgery - a comparison with the dihydroergotamine-heparin combination. Annales Chirurgiae et Gynaecologiae 1996;85(4):359-63. x-wiley/crsRef/19518381
64. Zouboulis P, Beltsios M, Lambiris E. The effect and safety of three low-molecular weight heparins (LMWHs) and warfarin in prevention of thromboembolism after hip surgery [Abstract]. Journal of Bone and Joint Surgery. British Volume 1997;79 Suppl 2:260. x-wiley/crsRef/19518383
65. Amaragiri SV, Lees TA. Elastic compression stockings for prevention of deep vein thrombosis (Cochrane Review). Cochrane Database of Systematic Reviews 2002, Issue 1.
66. Antiplatelet Trialists' Collaboration. Collaborative review of randomized trials of antiplatelet therapy-III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. BMJ 1994;308:235-46.
67. Bergqvist D, Benoni G, Bjorgell O, Fredin H, Hedlundh U, Nicolas S, et al. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. New England Journal of Medicine 1996;335(10):696-700.
68. Clarke M, Oxman AD, editors. Optimal search strategies for RCTs. Cochrane Reviewers Handbook 4.1.1 [updated December 2000]; Appendix 5c. In: The Cochrane Library, Issue 2, 2001. Oxford: Update Software. Updated quarterly.
69. Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. New England Journal of Medicine 1988;318:1162-73.
70. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ 1994;309:1286-91.
71. Haake DA, Berkman SA. Venous thromboembolic disease after hip surgery. Risk factors, prophylaxis and diagnosis. Clinical Orthopaedics and Related Research 1989;242:212-31.
72. Haas S. The role of low-molecular-weight heparins in the prevention of venous thrombosis in surgery with special reference to enoxaparin. Haemostasis 1996;26 Suppl 2:39-48.
73. Jorgensen LN, Wille-Jorgensen P, Hauch O. Prophylaxis of postoperative thromboembolism with low molecular weight heparins. British Journal of Surgery 1993;80:689-704.
74. Jorgensen PS, Strandberg C, Wille-Jorgensen P, Torholm C, Neergard K, Paaske BP, at al. Early preoperative thromboprophylaxis with Klexane in hip fracture surgery. A placebo controlled study. Unpublished report - dated 1995.
75. Lassen MR, Borris LC, Christiansen HM, Schott P, Olsen AD, Sorensen JV, et al. Clinical trials with low molecular weight heparins in the prevention of postoperative thromboembolic complications: a meta-analysis. Seminars in Thrombosis & Hemostasis 1991;17 Suppl 3:284-290.
76. Nurmohamed MT, Rosendaal FD, Bulleer HR, Dekker E, Hommes DW, Vandenbroucke JP, Briet E. Low molecular weight heparin versus standard heparin in general and orthopaedic surgery: a meta analysis. Lancet 1992;340:152-6.
77. Parker MJ, Handoll HHG, Griffiths R. Anaesthesia for hip fracture surgery in adults (Cochrane Review). Cochrane Database of Systematic Reviews 2002, Issue 1.
78. Parker-Williams J, Vickers R. Major orthopaedic surgery on the leg and thromboembolism. BMJ 1991;303:531-2.
79. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 2000;355:1295-303.
80. Rodgers A, Gray DH, MacMahon S. Pharmacological thromboprophylaxis in hip and knee surgery: a survey of New Zealand orthopaedic surgeons. Austalian and New Zealand Journal of Surgery 1994;64:167-72.
81. Roise O, Nurmohamed M, Reijnders P, Touzard R, Stiekema J, Bachman F, et al. A multicentre, randomised, assessor-blind, pilot study comparing the efficacy in the prophylaxis of DVT and the safety of Orgaran (Org 10172), Fragmin, Clexane/Lovenox in patients undergoing surgery for a fractured hip [abstract 273]. Thrombosis and Haemostasis 1993;69(6):620.
82. Salzman EW, Harris WH. Prevention of venous thromboembolism in orthopaedic patients. Journal of Bone and Joint Surgery. American Volume 1976;58:903-13.
83. Sevitt S, Gallagher NG. Venous thrombosis and pulmonary embolism. A clinico-pathological study in injured and burned patients. British Journal of Surgery 1961;48:475-89.
84. Hip Fracture Guideline Development Group. Prevention and management of hip fracture in older people. A national clinical guideline (No. 56). Edinburgh: Scottish Intercollegiate Guidelines Network (www.sign.ac.uk), 2002.
85. Todd CJ, Freeman CJ, Camilleri-Ferrante C, Palmer CR, Hyder A, Laxton CE, et al. Differences in mortality after fracture of the hip: the East Anglian audit. BMJ 1995;310:904-8.
86. Toulemonde F, Kher A. Optimal duration for prophylaxis of deep vein thrombosis: The new focus? Clinical & Applied Thrombosis/Hemostasis 1996;2(4):285-8.
87. Handoll HHG, Farrar MJ, McBirnie J, Tytherleigh-Strong G, Awal KA, Milne AA, Gillespie WJ. Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures (Cochrane Review). Cochrane Database of Systematic Reviews 2002, Issue 1.
88. Gillespie WJ, Awal KH, Farrar MJ, Handoll HHG, McBirnie J, Milne AA, Tytherleigh-Strong G. Prophylaxis against deep vein thrombosis and pulmonary embolism in hip fracture surgery [Protocol for a Cochrane Review]. Cochrane Database of Systematic Reviews 1997, Issue 3.